Intra-Cellular Therap
ITCI131.8700.00% ( 0.000 )
Intra-Cellular Therap (ITCI)
Intra-Cellular Therapies, Inc., a biopharmaceutical company, focuses on the discovery, clinical development, and commercialization of small molecule drugs that...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 131.870
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- StockTitan · Apr 26 at 10:05 PM
PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors | BNTC Stock News
- Market Beat · Apr 10, 2025 at 05:12 AM
Fmr LLC Reduces Stock Position in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
- Market Beat · Apr 6, 2025 at 01:10 AM
Intra-Cellular Therapies (NASDAQ:ITCI) Earns Hold Rating from Analysts at StockNews.com
- Market Beat · Apr 4, 2025 at 03:05 PM
Value Stocks To Watch Now - April 2nd
- Market Beat · Apr 4, 2025 at 01:02 PM
Medical Stocks To Keep An Eye On - April 2nd
- Tip Ranks · Apr 2, 2025 at 03:30 PM
Intra-Cellular Therapies Completes Merger with Johnson & Johnson
